These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 24859148)

  • 1. Role of lipid rafts and GM1 in the segregation and processing of prion protein.
    Botto L; Cunati D; Coco S; Sesana S; Bulbarelli A; Biasini E; Colombo L; Negro A; Chiesa R; Masserini M; Palestini P
    PLoS One; 2014; 9(5):e98344. PubMed ID: 24859148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of prion proteins to lipid membranes.
    Critchley P; Kazlauskaite J; Eason R; Pinheiro TJ
    Biochem Biophys Res Commun; 2004 Jan; 313(3):559-67. PubMed ID: 14697227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cellular prion protein with a monoacylated glycosylphosphatidylinositol anchor modifies cell membranes, inhibits cell signaling and reduces prion formation.
    Bate C; Williams A
    Prion; 2011; 5(2):65-8. PubMed ID: 21738009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PrP Knockout Cells Expressing Transmembrane PrP Resist Prion Infection.
    Marshall KE; Hughson A; Vascellari S; Priola SA; Sakudo A; Onodera T; Baron GS
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27847358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glypican-1 mediates both prion protein lipid raft association and disease isoform formation.
    Taylor DR; Whitehouse IJ; Hooper NM
    PLoS Pathog; 2009 Nov; 5(11):e1000666. PubMed ID: 19936054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of rafts in the fibrillization and aggregation of prions.
    Pinheiro TJ
    Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of detergent-insoluble complexes containing the cellular prion protein and its scrapie isoform.
    Naslavsky N; Stein R; Yanai A; Friedlander G; Taraboulos A
    J Biol Chem; 1997 Mar; 272(10):6324-31. PubMed ID: 9045652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prion protein and lipid rafts.
    Taylor DR; Hooper NM
    Mol Membr Biol; 2006; 23(1):89-99. PubMed ID: 16611584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of lipid rafts in prion protein biology.
    Lewis V; Hooper NM
    Front Biosci (Landmark Ed); 2011 Jan; 16(1):151-68. PubMed ID: 21196164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doppel and PrPC co-immunoprecipitate in detergent-resistant membrane domains of epithelial FRT cells.
    Caputo A; Sarnataro D; Campana V; Costanzo M; Negro A; Sorgato MC; Zurzolo C
    Biochem J; 2009 Dec; 425(2):341-51. PubMed ID: 19888917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PrP(C) association with lipid rafts in the early secretory pathway stabilizes its cellular conformation.
    Sarnataro D; Campana V; Paladino S; Stornaiuolo M; Nitsch L; Zurzolo C
    Mol Biol Cell; 2004 Sep; 15(9):4031-42. PubMed ID: 15229281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Docosahexaenoic and eicosapentaenoic acids increase prion formation in neuronal cells.
    Bate C; Tayebi M; Diomede L; Salmona M; Williams A
    BMC Biol; 2008 Sep; 6():39. PubMed ID: 18789130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translocation of cellular prion protein to non-lipid rafts protects human prion-mediated neuronal damage.
    Jeong JK; Moon MH; Lee YJ; Seol JW; Park SY
    Int J Mol Med; 2012 Mar; 29(3):387-92. PubMed ID: 22179431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insight into the PrPC-->PrPSc conversion from the structures of antibody-bound ovine prion scrapie-susceptibility variants.
    Eghiaian F; Grosclaude J; Lesceu S; Debey P; Doublet B; Tréguer E; Rezaei H; Knossow M
    Proc Natl Acad Sci U S A; 2004 Jul; 101(28):10254-9. PubMed ID: 15240887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The glycosylphosphatidylinositol anchor is a major determinant of prion binding and replication.
    Bate C; Tayebi M; Williams A
    Biochem J; 2010 Apr; 428(1):95-101. PubMed ID: 20196773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A receptor for infectious and cellular prion protein.
    Martins VR
    Braz J Med Biol Res; 1999 Jul; 32(7):853-9. PubMed ID: 10454744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol transporter ATP-binding cassette A1 (ABCA1) is elevated in prion disease and affects PrPC and PrPSc concentrations in cultured cells.
    Kumar R; McClain D; Young R; Carlson GA
    J Gen Virol; 2008 Jun; 89(Pt 6):1525-1532. PubMed ID: 18474570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sphingomyelin chain length influences the distribution of GPI-anchored proteins in rafts in supported lipid bilayers.
    Garner AE; Smith DA; Hooper NM
    Mol Membr Biol; 2007; 24(3):233-42. PubMed ID: 17520480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational transitions in peptides containing two putative alpha-helices of the prion protein.
    Zhang H; Kaneko K; Nguyen JT; Livshits TL; Baldwin MA; Cohen FE; James TL; Prusiner SB
    J Mol Biol; 1995 Jul; 250(4):514-26. PubMed ID: 7542350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sheep scrapie susceptibility-linked polymorphisms do not modulate the initial binding of cellular to disease-associated prion protein prior to conversion.
    Rigter A; Bossers A
    J Gen Virol; 2005 Sep; 86(Pt 9):2627-2634. PubMed ID: 16099922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.